Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging
References (15)
- et al.
Tacrine in Alzheimer's disease
Lancet
(1991) - et al.
Stage-dependent reductions of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type
Psychiatry Res.
(1989) - et al.
Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer's disease
Lancet
(1990) - et al.
Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats
Pharmacol. Biochem. Behav.
(1991) - et al.
Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain
Neurosci. Lett.
(1992) - et al.
Tetrahydroaminoacridine and Alzheimer's disease. For the few, but we don't know which few
Br. Med. J.
(1994) - et al.
Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG
Psychopharmacology
(1987)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1995 Published by Elsevier Ireland Ltd.